Steven M Paul - Net Worth and Insider Trading
Steven M Paul Net Worth
The estimated net worth of Steven M Paul is at least $199 Million dollars as of 2024-09-20. Steven M Paul is the Director of Bright Horizons Family Solutions Inc and owns about 763,650 shares of Bright Horizons Family Solutions Inc (BFAM) stock worth over $106 Million. Steven M Paul is the EVP, Science and Technology of Eli Lilly and Co and owns about 50,300 shares of Eli Lilly and Co (LLY) stock worth over $47 Million. Steven M Paul is also the PRESIDENT & CEO of Karuna Therapeutics Inc and owns about 108,849 shares of Karuna Therapeutics Inc (KRTX) stock worth over $36 Million. Besides these, Steven M Paul also holds Voyager Therapeutics Inc (VYGR) , Sage Therapeutics Inc (SAGE) , Alnylam Pharmaceuticals Inc (ALNY) . Details can be seen in Steven M Paul's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steven M Paul has not made any transactions after 2021-08-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Steven M Paul
Steven M Paul Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steven M Paul owns 5 companies in total, including Alnylam Pharmaceuticals Inc (ALNY) , Karuna Therapeutics Inc (KRTX) , and Sage Therapeutics Inc (SAGE) among others .
Click here to see the complete history of Steven M Paul’s form 4 insider trades.
Insider Ownership Summary of Steven M Paul
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ALNY | Alnylam Pharmaceuticals Inc | 2020-12-18 | director |
KRTX | Karuna Therapeutics Inc | 2021-08-18 | director & President & CEO |
SAGE | Sage Therapeutics Inc | 2019-03-21 | director |
2016-01-14 | director & President and CEO | ||
2008-02-04 | EVP & Science and Technology |
Steven M Paul Latest Holdings Summary
Steven M Paul currently owns a total of 6 stocks. Among these stocks, Steven M Paul owns 763,650 shares of Bright Horizons Family Solutions Inc (BFAM) as of May 1, 2015, with a value of $106 Million and a weighting of 53.16%. Steven M Paul owns 50,300 shares of Eli Lilly and Co (LLY) as of February 4, 2008, with a value of $47 Million and a weighting of 23.54%. Steven M Paul also owns 108,849 shares of Karuna Therapeutics Inc (KRTX) as of August 18, 2021, with a value of $36 Million and a weighting of 18.02%. The other 3 stocks Voyager Therapeutics Inc (VYGR) , Sage Therapeutics Inc (SAGE) , Alnylam Pharmaceuticals Inc (ALNY) have a combined weighting of 5.28% among all his current holdings.
Latest Holdings of Steven M Paul
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BFAM | Bright Horizons Family Solutions Inc | 2015-05-01 | 763,650 | 138.68 | 105,902,982 |
LLY | Eli Lilly and Co | 2008-02-04 | 50,300 | 932.33 | 46,895,948 |
KRTX | Karuna Therapeutics Inc | 2021-08-18 | 108,849 | 329.83 | 35,901,666 |
VYGR | Voyager Therapeutics Inc | 2016-01-14 | 872,351 | 6.12 | 5,338,788 |
SAGE | Sage Therapeutics Inc | 2019-03-21 | 646,830 | 7.59 | 4,909,440 |
ALNY | Alnylam Pharmaceuticals Inc | 2020-12-18 | 1,000 | 270.86 | 270,855 |
Holding Weightings of Steven M Paul
Steven M Paul Form 4 Trading Tracker
According to the SEC Form 4 filings, Steven M Paul has made a total of 0 transactions in Bright Horizons Family Solutions Inc (BFAM) over the past 5 years. The most-recent trade in Bright Horizons Family Solutions Inc is the sale of 20,000 shares on May 1, 2015, which brought Steven M Paul around $1 Million.
According to the SEC Form 4 filings, Steven M Paul has made a total of 0 transactions in Eli Lilly and Co (LLY) over the past 5 years. The most-recent trade in Eli Lilly and Co is the sale of 19,822 shares on February 4, 2008, which brought Steven M Paul around $1 Million.
According to the SEC Form 4 filings, Steven M Paul has made a total of 2 transactions in Karuna Therapeutics Inc (KRTX) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Karuna Therapeutics Inc is the acquisition of 2,364 shares on August 18, 2021, which cost Steven M Paul around $250,253.
More details on Steven M Paul's insider transactions can be found in the Insider Trading History of Steven M Paul table.Insider Trading History of Steven M Paul
- 1
Steven M Paul Trading Performance
GuruFocus tracks the stock performance after each of Steven M Paul's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steven M Paul is -0.42%. GuruFocus also compares Steven M Paul's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steven M Paul within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Steven M Paul's insider trading performs compared to the benchmark.
Steven M Paul Ownership Network
Steven M Paul Owned Company Details
What does Alnylam Pharmaceuticals Inc do?
Who are the key executives at Alnylam Pharmaceuticals Inc?
Steven M Paul is the director of Alnylam Pharmaceuticals Inc. Other key executives at Alnylam Pharmaceuticals Inc include EVP & Chief Commercial Officer Yvonne Greenstreet , EVP & Chief Commercial Officer Tolga Tanguler , and CMO & EVP Dev & Med Affairs Pushkal Garg .
Alnylam Pharmaceuticals Inc (ALNY) Insider Trades Summary
Over the past 18 months, Steven M Paul made no insider transaction in Alnylam Pharmaceuticals Inc (ALNY). Other recent insider transactions involving Alnylam Pharmaceuticals Inc (ALNY) include a net sale of 60,146 shares made by Yvonne Greenstreet , a net sale of 14,598 shares made by Pushkal Garg , and a net sale of 6,616 shares made by Jeffrey V. Poulton .
In summary, during the past 3 months, insiders sold 135,278 shares of Alnylam Pharmaceuticals Inc (ALNY) in total and bought 0 shares, with a net sale of 135,278 shares. During the past 18 months, 269,382 shares of Alnylam Pharmaceuticals Inc (ALNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 269,382 shares.
Alnylam Pharmaceuticals Inc (ALNY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alnylam Pharmaceuticals Inc Insider Transactions
Steven M Paul Mailing Address
Above is the net worth, insider trading, and ownership report for Steven M Paul. You might contact Steven M Paul via mailing address: C/o Eli Litty & Co, Liiy Corporate Center Dc 1093, Indianapolis In 46285.